Founder Entity Doubles Down on Li Ning as Institutions Exit Kingdee
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The most striking filing from early September: Viva China Holdings — the vehicle controlled by sportswear founder Li Ning himself — bought over $77 million worth of Li Ning shares across four consecutive trading days (Aug 28–Sep 3), filed September 7. This is a decisive, discretionary buy from the founding family. It pushes Viva China's stake higher at a time when the stock has been under pressure.
Meanwhile, two Western institutions moved in opposite directions on Chinese software firm Kingdee International. BlackRock sold $137M worth of shares on September 2, filed September 7. JPMorgan followed with a further $85M sale, filed September 8. Both are 5% owners, and the combined exit tops $220M — a significant coordinated withdrawal from China's enterprise software sector.
On the buy side, Pharmaron Beijing attracted persistent institutional interest. JPMorgan built a stake worth more than $130M across three separate purchases between August 20 and September 2. Morgan Stanley also added $10M in late August. Both filings arrived within days of each other, flagging fresh conviction in the Hong Kong-listed pharma services group — even as Pharmaron's own founder sold $9.5M on the A-share listing in August.
Note: these filings reflect positions as last disclosed and are most relevant around the 5% ownership threshold.
Stocks in this article
How this article was generated
- Generated
- 25 Sept 2026, 12:26
- Prompt version
- v1.0
- Data sources
- Institutional positioning
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.